发明名称 |
Compositions and methods for inhibiting norovirus infection |
摘要 |
A composition for use in inhibiting the binding of a Norovirus to the histo-blood group antigen on the surface of epithelia is disclosed. The composition may contain a therapeutically effective amount of a binding-inhibiting compound and a carrier and/or excipient. The compounds may competitively bind a Norovirus that has the capability of binding with the histo-blood group antigens of secretor blood type, including A, B, AB, and O blood types. The compositions may be administered to a human prior to or after infection by a Norovirus, to prevent, ameliorate, or reduce the effects of an infection. |
申请公布号 |
US9321803(B2) |
申请公布日期 |
2016.04.26 |
申请号 |
US201414326894 |
申请日期 |
2014.07.09 |
申请人 |
Children's Hospital Medical Center |
发明人 |
Jiang Xi;Tan Ming;Zhang Xufu |
分类号 |
A61K31/56;C07J41/00;C07J7/00;C07J9/00;C07J3/00 |
主分类号 |
A61K31/56 |
代理机构 |
Frost Brown Todd LLC |
代理人 |
Frost Brown Todd LLC |
主权项 |
1. A method for the inhibition of norovirus in a subject in need thereof, comprising the step of administering to the subject a therapeutically effective amount of a compound that inhibits binding of at least one Norovirus to a native histo blood group antigen of the subject, wherein said compound comprises a steroid structure and is selected from the group consisting ofor a pharmaceutically acceptable salt thereof,or a pharmaceutically acceptable salt thereof,or a pharmaceutically acceptable salt thereof,or a pharmaceutically acceptable salt thereof, andor a pharmaceutically acceptable salt thereof,and at least one diluent, carrier and or excipient. |
地址 |
Cincinnati OH US |